title: Targeting tumor stromal cells through a PDGF-beta receptor binding carrier.
authors.affiliation: Department of Pharmacokinetics, Toxicology and Targeting, Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands. J.Prakash@rug.nl
authors.forename: Jai
authors.initials: J
authors.lastname: Prakash
authors.forename: Edwin
authors.initials: E
authors.lastname: de Jong
authors.forename: Eduard
authors.initials: E
authors.lastname: Post
authors.forename: Ara K
authors.initials: AK
authors.lastname: Mohammad
authors.forename: Leonie
authors.initials: L
authors.lastname: Beljaars
authors.forename: Klaas
authors.initials: K
authors.lastname: Poelstra
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage* / Q000494:pharmacology; D004337:Drug Carriers; D051379:Mice; D041681:NIH 3T3 Cells; D009369:Neoplasms / Q000188:drug therapy*; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000008:administration & dosage* / Q000378:metabolism; D012709:Serum Albumin / Q000008:administration & dosage / Q000378:metabolism; D017154:Stromal Cells / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D012709:Serum Albumin; D004317:Doxorubicin; D020797:Receptor, Platelet-Derived Growth Factor beta